DE69900162T2 - Arzneimittel enthaltend Oxaliplatin - Google Patents

Arzneimittel enthaltend Oxaliplatin

Info

Publication number
DE69900162T2
DE69900162T2 DE69900162T DE69900162T DE69900162T2 DE 69900162 T2 DE69900162 T2 DE 69900162T2 DE 69900162 T DE69900162 T DE 69900162T DE 69900162 T DE69900162 T DE 69900162T DE 69900162 T2 DE69900162 T2 DE 69900162T2
Authority
DE
Germany
Prior art keywords
product containing
medicinal product
containing oxaliplatin
oxaliplatin
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE69900162T
Other languages
English (en)
Other versions
DE69900162D1 (de
Inventor
Nicholas H Anderson
Ross Blundell
Stephen Brown
David A England
Martin R Gray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10827600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69900162(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69900162D1 publication Critical patent/DE69900162D1/de
Application granted granted Critical
Publication of DE69900162T2 publication Critical patent/DE69900162T2/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69900162T 1998-02-25 1999-02-25 Arzneimittel enthaltend Oxaliplatin Ceased DE69900162T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804013.2A GB9804013D0 (en) 1998-02-25 1998-02-25 Formulations

Publications (2)

Publication Number Publication Date
DE69900162D1 DE69900162D1 (de) 2001-08-02
DE69900162T2 true DE69900162T2 (de) 2002-04-18

Family

ID=10827600

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69900162T Ceased DE69900162T2 (de) 1998-02-25 1999-02-25 Arzneimittel enthaltend Oxaliplatin

Country Status (28)

Country Link
US (1) US6306902B1 (de)
EP (1) EP0943331B1 (de)
JP (1) JP4430229B2 (de)
KR (1) KR20010041182A (de)
CN (1) CN1152718C (de)
AR (1) AR015524A1 (de)
AT (1) ATE202472T1 (de)
AU (1) AU757101B2 (de)
BR (1) BR9908273A (de)
CA (1) CA2261500C (de)
CZ (1) CZ302196B6 (de)
DE (1) DE69900162T2 (de)
DK (1) DK0943331T3 (de)
ES (1) ES2161085T3 (de)
GB (1) GB9804013D0 (de)
GR (1) GR3036646T3 (de)
GT (1) GT199900019A (de)
HK (1) HK1036405A1 (de)
HU (1) HU224611B1 (de)
IL (1) IL137772A (de)
MX (1) MXPA00008195A (de)
NO (1) NO329900B1 (de)
PL (1) PL197948B1 (de)
PT (1) PT943331E (de)
RU (1) RU2207857C2 (de)
UA (1) UA70316C2 (de)
WO (1) WO1999043355A2 (de)
ZA (1) ZA991489B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
JP4884587B2 (ja) * 1998-10-14 2012-02-29 デビオファーム・ソシエテ・アノニム オキサリ白金調製物の容器包装
RU2252022C2 (ru) * 1999-08-30 2005-05-20 Дебиофарм С.А. Стабильный фармацевтический препарат оксалиплатины для парентерального введения
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
WO2002047725A2 (fr) * 2000-12-12 2002-06-20 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
ATE365037T1 (de) 2001-03-02 2007-07-15 Debiopharm Sa Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens
WO2003004505A1 (en) * 2001-07-02 2003-01-16 Debiopharm S.A. Oxaliplatin active substance with a very low content of oxalic acid
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
US20050020556A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
GB2441445B (en) * 2003-08-28 2008-04-23 Mayne Pharma Ltd Acid containing oxaliplatin formulation
EP2243480A1 (de) * 2003-08-28 2010-10-27 Mayne Pharma Pty Ltd Pharmazeutische Zubereitung enthaltend Oxaliplatin und eine Säure
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
CZ300795B6 (cs) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Farmaceutická kompozice a zpusob její výroby
EP1704156A1 (de) 2003-11-25 2006-09-27 Platco Technologies (Proprietary) Limited Platin(ii)-komplexe, herstellung und verwendung
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
WO2005102312A1 (en) * 2004-04-27 2005-11-03 Mayne Pharma Limited Concentrated oxaliplatin solutions
US7589225B2 (en) 2004-09-01 2009-09-15 Platco Technologies (Proprietary) Limited Preparation of platinum(II) complexes
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2006103691A1 (en) * 2005-03-28 2006-10-05 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (ii) antitumour agents
EP1874290A1 (de) * 2005-04-09 2008-01-09 Vuab Pharma A. S. Verfahren zur herstellung einer oxaliplatin-zubereitung
WO2007029268A2 (en) * 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
RU2008135369A (ru) 2006-01-30 2010-03-10 Платко Текнолоджис (Проприэтэри) Лимитед (Za) Получение комплексов платины(ii)
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
KR20090102844A (ko) * 2007-01-22 2009-09-30 플리바-라케마 에이. 에스. 알콜 당-계 완충액을 함유한 옥살리플라틴 약제학적 조성물
EP2152239A1 (de) * 2007-11-12 2010-02-17 Intas Pharmaceuticals Limited Stabile oxaliplatinzusammensetzung zur parenteralen verabreichung
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
US9023834B2 (en) * 2008-11-13 2015-05-05 Taigen Biotechnology Co., Ltd. Lyophilization formulation
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
WO2011034394A2 (ko) 2009-09-21 2011-03-24 주식회사 중외제약 옥살리플라틴의 나노 입자 및 이를 제조하는 방법
CN102274171A (zh) * 2011-08-04 2011-12-14 上海希迪制药有限公司 一种奥沙利铂注射剂
CN104523674B (zh) * 2014-12-11 2017-10-24 广州市上为医药科技有限公司 一种以奥沙利铂为主药成分的注射用组合物
KR101683635B1 (ko) * 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CN104829653B (zh) * 2015-05-06 2016-03-23 山东罗欣药业集团股份有限公司 一种奥沙利铂水合物晶体及其冻干粉针剂
KR20200099172A (ko) 2018-01-12 2020-08-21 (주) 메티메디제약 만성 염증성 질환의 치료 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
PT93772A (pt) 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
US5214174A (en) 1989-12-15 1993-05-25 Tsumura & Co. Platinum complex and anti-tumor agent comprising said complex as active ingredient
JPH04185601A (ja) * 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
NZ245112A (en) * 1991-11-15 1995-07-26 Smithkline Beecham Corp Pharmaceutical composition comprising a camptothecin analog and a platinum coordination compound
JPH0776230B2 (ja) * 1992-01-13 1995-08-16 田中貴金属工業株式会社 白金化合物の製造方法
JPH05238936A (ja) 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd カルシトリオールの水性液剤
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
JP2673331B2 (ja) * 1993-01-12 1997-11-05 田中貴金属工業 株式会社 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
AU5416394A (en) * 1992-11-24 1994-06-22 Debiopharm S.A. Cisplatinum/oxaliplatinum combination
JP3025602B2 (ja) * 1993-05-21 2000-03-27 デビオファーム エス．アー． 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
KR100365171B1 (ko) 1994-08-08 2003-02-19 드바이오팜 에스.아. 약학적으로안정한옥살리플라티늄제제
ES2206478T3 (es) * 1994-11-11 2004-05-16 Debiopharm S.A. Composiciones carcinostaticas que contienen cis-oxaliplatino y otra u otras sustancias carcinostaticas compatibles.
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
EP0801070B1 (de) 1996-04-10 2003-04-16 Debiopharm S.A. Verfahren zur Herstellung von Platin Verbindungen
JPH09294809A (ja) 1996-05-07 1997-11-18 Terumo Corp 薬液注入器具
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung

Also Published As

Publication number Publication date
BR9908273A (pt) 2000-10-24
AR015524A1 (es) 2001-05-02
ES2161085T3 (es) 2001-11-16
PL343021A1 (en) 2001-07-30
GT199900019A (es) 2000-08-04
ZA991489B (en) 1999-09-30
NO329900B1 (no) 2011-01-24
JP4430229B2 (ja) 2010-03-10
DE69900162D1 (de) 2001-08-02
ATE202472T1 (de) 2001-07-15
JP2002504524A (ja) 2002-02-12
KR20010041182A (ko) 2001-05-15
HUP0103707A3 (en) 2004-07-28
AU757101B2 (en) 2003-01-30
WO1999043355A2 (en) 1999-09-02
EP0943331B1 (de) 2001-06-27
UA70316C2 (uk) 2004-10-15
PT943331E (pt) 2001-12-28
CN1152718C (zh) 2004-06-09
GR3036646T3 (en) 2001-12-31
GB9804013D0 (en) 1998-04-22
NO20004240L (no) 2000-10-18
CZ20003089A3 (cs) 2000-12-13
WO1999043355A3 (en) 1999-11-04
HK1036405A1 (en) 2002-01-04
AU2632499A (en) 1999-09-15
CZ302196B6 (cs) 2010-12-15
IL137772A (en) 2006-04-10
DK0943331T3 (da) 2001-10-15
NO20004240D0 (no) 2000-08-24
CN1291886A (zh) 2001-04-18
HU224611B1 (hu) 2005-11-28
PL197948B1 (pl) 2008-05-30
CA2261500C (en) 2001-07-17
EP0943331A3 (de) 1999-11-03
RU2207857C2 (ru) 2003-07-10
EP0943331A2 (de) 1999-09-22
HUP0103707A2 (hu) 2002-02-28
MXPA00008195A (es) 2004-11-22
CA2261500A1 (en) 1999-08-25
US6306902B1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DE69900162T2 (de) Arzneimittel enthaltend Oxaliplatin
ATE240732T1 (de) Ziprasidonhaltige arzneimittel
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
FI954402A0 (fi) Uusi farmaseuttinen tuote
ATE318137T1 (de) Parenteral anzuwendendes bisphosphonathaltiges arzneimittel
NO20005218L (no) Farmasöytisk aerosolpreparat
DE69513671D1 (de) Arzneimittel
DE59912838D1 (de) Pharmazeutisches faktor vii-präparat
DE69840622D1 (de) Kosmetikprodukt
DK1466615T3 (da) Farmaceutisk præparat
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
GB9801538D0 (en) Pharmaceutical product
DE29713884U1 (de) Tablettenspender
DE29513226U1 (de) Tablettenspender
ATE237529T1 (de) Tablettenspender
ID30032A (id) Formulasi farmasi
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
DE60008237D1 (de) Lamivudin enthaltende arzneimittel
DE29821954U1 (de) Warentrennstab
DE29708649U1 (de) Tablettenspender
DE29800666U1 (de) Tablettenspender
DE69819203D1 (de) Trinkbares arzneimittel
DE29811862U1 (de) Vitamin-Tablettenspender
DE29720448U1 (de) Stabilisiertes Kombinationsarzneimittel
UA3066S (uk) Упаковка медичного препарату

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8310 Action for declaration of annulment
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

8311 Complete invalidation